Michael Robinson

Michael Robinson has been a Managing Director in the Healthcare Investment Banking Group at Jefferies since 2009, focused exclusively on medical devices. Prior to joining Jefferies he served for a decade at UBS Investment Bank as a Managing Director and prior to joining UBS he was a Managing Director and Head of Healthcare M&A at Salomon Smith Barney.

Over a 25 year career in investment banking Mr. Robinson has been active in the aesthetics space including most recently as lead financial advisor to HydraFacial on its sale to Vesper Healthcare (now Beauty Health), and as lead-left bookrunner on the IPO and subsequent follow-on offering of Establishment Labs. Previously he has led transactions for TELA Bio, Sisram/Alma Lasers, NuSil, Lumenis, Coherent Medical, and ESC Medical.

Mr. Robinson has an MBA from Columbia Business School and a BS in Chemical Engineering from the University of California, Berkeley.